163 related articles for article (PubMed ID: 37700453)
41. Systemic Lupus Erythematous and Obstructive Sleep Apnea: A Possible Association.
Meidan R; Elalouf O; Tauman R; Furer V; Polachek A; Wollman J; Eviatar T; Zisapel M; Levartovsky D; Seyman E; Elkayam O; Paran D
Life (Basel); 2023 Mar; 13(3):. PubMed ID: 36983852
[TBL] [Abstract][Full Text] [Related]
42. Cigarette smoking and disease activity in systemic lupus erythematosus.
Ghaussy NO; Sibbitt W; Bankhurst AD; Qualls CR
J Rheumatol; 2003 Jun; 30(6):1215-21. PubMed ID: 12784392
[TBL] [Abstract][Full Text] [Related]
43. Neuropsychiatric events at the time of diagnosis of systemic lupus erythematosus: an international inception cohort study.
Hanly JG; Urowitz MB; Sanchez-Guerrero J; Bae SC; Gordon C; Wallace DJ; Isenberg D; Alarcón GS; Clarke A; Bernatsky S; Merrill JT; Petri M; Dooley MA; Gladman D; Fortin PR; Steinsson K; Bruce I; Manzi S; Khamashta M; Zoma A; Aranow C; Ginzler E; Van Vollenhoven R; Font J; Sturfelt G; Nived O; Ramsey-Goldman R; Kalunian K; Douglas J; Thompson K; Farewell V;
Arthritis Rheum; 2007 Jan; 56(1):265-73. PubMed ID: 17195230
[TBL] [Abstract][Full Text] [Related]
44. The SLICC-FI Predicts Damage Accrual in SLE Patients. Data From the Almenara Lupus Cohort.
Elera-Fitzcarrald C; Gamboa-Cárdenas RV; Reatégui-Sokolova C; Pimentel-Quiroz V; Rodriguez-Bellido Z; Pastor-Asurza CA; Perich-Campos R; Alarcón GS; Ugarte-Gil MF
Lupus; 2022 Nov; 31(13):1666-1670. PubMed ID: 36165429
[TBL] [Abstract][Full Text] [Related]
45. Effect of Disease Activity on Organ Damage Progression in Systemic Lupus Erythematosus: University of Toronto Lupus Clinic Cohort.
Urowitz MB; Gladman DD; Ibañez D; Su J; Mursleen S; Sayani A; Ross Terres JA; Iczkovitz S
J Rheumatol; 2021 Jan; 48(1):67-73. PubMed ID: 32238510
[TBL] [Abstract][Full Text] [Related]
46. Elevated levels of soluble fractalkine in active systemic lupus erythematosus: potential involvement in neuropsychiatric manifestations.
Yajima N; Kasama T; Isozaki T; Odai T; Matsunawa M; Negishi M; Ide H; Kameoka Y; Hirohata S; Adachi M
Arthritis Rheum; 2005 Jun; 52(6):1670-5. PubMed ID: 15934075
[TBL] [Abstract][Full Text] [Related]
47. Evaluating the Properties of a Frailty Index and Its Association With Mortality Risk Among Patients With Systemic Lupus Erythematosus.
Legge A; Kirkland S; Rockwood K; Andreou P; Bae SC; Gordon C; Romero-Diaz J; Sanchez-Guerrero J; Wallace DJ; Bernatsky S; Clarke AE; Merrill JT; Ginzler EM; Fortin P; Gladman DD; Urowitz MB; Bruce IN; Isenberg DA; Rahman A; Alarcón GS; Petri M; Khamashta MA; Dooley MA; Ramsey-Goldman R; Manzi S; Steinsson K; Zoma AA; Aranow C; Mackay M; Ruiz-Irastorza G; Lim SS; Inanc M; van Vollenhoven RF; Jonsen A; Nived O; Ramos-Casals M; Kamen DL; Kalunian KC; Jacobsen S; Peschken CA; Askanase A; Hanly JG
Arthritis Rheumatol; 2019 Aug; 71(8):1297-1307. PubMed ID: 30771242
[TBL] [Abstract][Full Text] [Related]
48. The sense of smell in systemic lupus erythematosus.
Shoenfeld N; Agmon-Levin N; Flitman-Katzevman I; Paran D; Katz BS; Kivity S; Langevitz P; Zandman-Goddard G; Shoenfeld Y
Arthritis Rheum; 2009 May; 60(5):1484-7. PubMed ID: 19404932
[TBL] [Abstract][Full Text] [Related]
49. Assessment of clinical manifestations, disease activity and organ damage in 996 Korean patients with systemic lupus erythematosus: comparison with other Asian populations.
Joo YB; Bae SC
Int J Rheum Dis; 2015 Feb; 18(2):117-28. PubMed ID: 25524656
[TBL] [Abstract][Full Text] [Related]
50. High predictive value of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for survival in systemic lupus erythematosus.
Nived O; Jönsen A; Bengtsson AA; Bengtsson C; Sturfelt G
J Rheumatol; 2002 Jul; 29(7):1398-400. PubMed ID: 12136895
[TBL] [Abstract][Full Text] [Related]
51. The Prognostic Nutritional Index and Nutritional Risk Index Are Associated with Disease Activity in Patients with Systemic Lupus Erythematosus.
Correa-Rodríguez M; Pocovi-Gerardino G; Callejas-Rubio JL; Fernández RR; Martín-Amada M; Cruz-Caparros MG; Ortego-Centeno N; Rueda-Medina B
Nutrients; 2019 Mar; 11(3):. PubMed ID: 30884776
[TBL] [Abstract][Full Text] [Related]
52. Long-Term Clinical Outcomes in a Cohort of Adults With Childhood-Onset Systemic Lupus Erythematosus.
Groot N; Shaikhani D; Teng YKO; de Leeuw K; Bijl M; Dolhain RJEM; Zirkzee E; Fritsch-Stork R; Bultink IEM; Kamphuis S
Arthritis Rheumatol; 2019 Feb; 71(2):290-301. PubMed ID: 30152151
[TBL] [Abstract][Full Text] [Related]
53. Association of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index with measures of disease activity and health status in patients with systemic lupus erythematosus.
Stoll T; Stucki G; Malik J; Pyke S; Isenberg DA
J Rheumatol; 1997 Feb; 24(2):309-13. PubMed ID: 9034988
[TBL] [Abstract][Full Text] [Related]
54. Chronic high-dose glucocorticoid therapy triggers the development of chronic organ damage and worsens disease outcome in systemic lupus erythematosus.
Tarr T; Papp G; Nagy N; Cserép E; Zeher M
Clin Rheumatol; 2017 Feb; 36(2):327-333. PubMed ID: 27889859
[TBL] [Abstract][Full Text] [Related]
55. Cognitive impairment in systemic lupus erythematosus women with elevated autoantibodies and normal single photon emission computerized tomography.
Peretti CS; Peretti CR; Kozora E; Papathanassiou D; Chouinard VA; Chouinard G
Psychother Psychosom; 2012; 81(5):276-85. PubMed ID: 22832425
[TBL] [Abstract][Full Text] [Related]
56. Association of calreticulin expression with disease activity and organ damage in systemic lupus erythematosus patients.
Wang Y; Xie J; Liu Z; Fu H; Huo Q; Gu Y; Liu Y
Exp Ther Med; 2017 May; 13(5):2577-2583. PubMed ID: 28565882
[TBL] [Abstract][Full Text] [Related]
57. Olfactory function in systemic lupus erythematosus and systemic sclerosis. A longitudinal study and review of the literature.
Bombini MF; Peres FA; Lapa AT; Sinicato NA; Quental BR; Pincelli ÁSM; Amaral TN; Gomes CC; Del Rio AP; Marques-Neto JF; Costallat LTL; Fernandes PT; Cendes F; Rittner L; Appenzeller S
Autoimmun Rev; 2018 Apr; 17(4):405-412. PubMed ID: 29444467
[TBL] [Abstract][Full Text] [Related]
58. Association of Systemic Lupus International Collaborating Clinics Frailty Index With Damage in Systemic Lupus Erythematosus Patients: Results From a Multiethnic, Multicenter US Cohort of Patients With Lupus.
Ugarte-Gil MF; Dubey J; McGwin G; Reveille JD; Vilá LM; Alarcón GS
Arthritis Care Res (Hoboken); 2023 Mar; 75(3):585-589. PubMed ID: 35255194
[TBL] [Abstract][Full Text] [Related]
59. Utility of the AVISE Connective Tissue Disease test in predicting lupus diagnosis and progression.
Liang E; Taylor M; McMahon M
Lupus Sci Med; 2020; 7(1):e000345. PubMed ID: 32231785
[TBL] [Abstract][Full Text] [Related]
60. Natural Killer and Natural Killer T Cells in Juvenile Systemic Lupus Erythematosus: Relation to Disease Activity and Progression.
Zahran AM; Abdel-Rahim MH; Elsayh KI; Hassanien MM; Mahran SA; Hetta HF
Arch Immunol Ther Exp (Warsz); 2019 Jun; 67(3):161-169. PubMed ID: 30944972
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
